Author

Xiaoling Ke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alicia Lindeman· 1 shared Brian Kelly· 1 shared Caroline Gubser KelleriD· 1 shared Carsten Russ· 1 shared Chian Yang· 1 shared Daniel J. Ho· 1 shared Frederic D. SigoillotiD· 1 shared Gilberto J Soler-LlavinaiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alicia Lindeman

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

DRUG-seq Provides Unbiased Biological Activity Readouts for Drug Discovery

Jingyao Li, Daniel J. Ho, Martin Hénault, Chian Yang, Marilisa Neri, Robin Ge, Steffen Renner, Leandra Mansur, Alicia Lindeman, Brian Kelly, Tayfun Tumkaya, Xiaoling Ke, Gilberto J Soler-Llavina, Gopi Shanker, Carsten Russ, , Robert J. Ihry

DRUG-seq provides high-throughput, unbiased transcriptomic data for drug discovery, demonstrating reproducibility and mechanism-of-action resolution for diverse compounds.

ACS Chemical Biology · May 4, 2022Peer-reviewedGenomics